Zevra Therapeutics, Inc. will present at the Citizens Life Sciences Conference in Miami Beach on March 11, 2026, at 9:00 a.m. ET. The company’s lead product, marketed in the U.S. for Niemann-Pick disease type C, a rare neurodegenerative disorder, showcases its ability to advance therapies. Zevra focuses on providing therapies for people with rare diseases and has a pipeline of rare disease programs. The company is patient-centric and aims to create long-term value for patients, partners, and shareholders. For more information, visit www.zevra.com.

Read more at GlobeNewswire: Zevra Therapeutics to Present at the Citizens Life Sciences